🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

When a leading multinational pharmaceutical company faced the challenge of managing diverse R&D data from thousands of instruments, they turned to Dotmatics Luma for a solution. Learn more: dotmatics.com/case-studies/b…

Dotmatics has been featured in the Intl. Business Times , highlighting how Dotmatics is empowering scientists to accelerate their research and achieve groundbreaking results with Luma and . Read the full article to learn more: dotmatics.com/news/ibt-ai-po…

We are excited to announce the launch of Luma Antibody & Protein Engineering solution, a comprehensive end-to-end solution for streamlining the antibody discovery and development process, with an emphasis on monoclonal and multispecific antibodies!

Introducing the all-in-one Luma Antibody & Protein Engineering solution. Powered by industry-trusted tools like Geneious and GraphPad Prism, this groundbreaking platform is transforming biologics R&D. For More information on this solution, visit our page: dotmatics.com/luma/antibody-…

The Luma Antibody & Protein Engineering Solution is the first in our series of custom-built, multimodal solutions powered by the Luma platform! This new solution integrates industry-leading tools like Geneious and GraphPad Prism for seamless R&D workflows. dotmatics.com/blog/new-dotma…

Strategic use of R&D data can unlock massive opportunities—but success requires the right tools, partnerships, and preparation. Learn how Dotmatics Luma platform simplifies data management, unites fragmented systems, and empowers better insights! dotmatics.com/blog/maximize-…

Dotmatics has been featured in Fast Company's recent article: AI’s Quiet Revolution is Accelerating Drug Discovery, Education and More. Discover how AI's quiet revolution is transforming industries like drug discovery and education! 💊📚 dotmatics.com/news/fast-comp…

🖥️ Watch our on-demand webinar to discover how Geneious Luma provides unparalleled precision and efficiency in the discovery of next-generation multispecific antibodies (msAbs), presented by Christian Olsen! Watch the webinar here: dotmatics.com/webinars/revol…

As 2024 comes to an end, we want to take a moment to express our gratitude to our amazing customers. Your relentless pursuit of discovery continues to inspire and drive meaningful progress in the world. Happy Holidays, from all of us at Dotmatics! ⭐️

We are excited to announce we will be exhibiting at SLAS 2025 in San Diego! Visit our booth 2313 at the San Diego Convention Center to meet with our team of subject matter experts and learn more about Luma! For more information, visit our page: dotmatics.com/events/slas-20…

Managing complex data from multiple instruments doesn’t have to be a hassle. 🖥️ Catch the live replay of Alister Campbell’s Achema 2024 presentation (dotmatics.zoom.us/webinar/regist…) to see real-world examples of how labs are cutting down on manual work and unlocking new insights.

From accelerating research to reducing costs, AI-powered solutions are reshaping how we develop life-saving treatments. Want to see how? Watch this ABC News feature with our VP of Biologics Christian Olsen and learn how #AI is revolutionizing medicine. dotmatics.com/news/abc-news-…

Croda, a leader in sustainable, high-performance ingredient development, faced challenges in managing its vast R&D data and fostering global collaboration. To overcome these barriers, Croda implemented Dotmatics ELN and Data Discovery Platform. Learn More dotmatics.com/case-studies/o…

#AI is transforming life sciences, but unlocking its full potential in 2025 takes more than just technology—it requires better data strategies, smarter workflows, and seamless AI integration.💡 Dotmatics and Databricks are making this a reality. dotmatics.com/blog/building-…

🚨 New ebook alert! As the life sciences landscape transforms, staying informed on the latest trends is essential for researchers and innovators. Our latest ebook highlights the 3 biggest trends set to reshape drug discovery in 2025 and beyond. dotmatics.com/whitepapers/3-…

💡 Dotmatics Luma is redefining drug discovery with #AI! Your ELN just got smarter—integrating AI-powered insights, private & public datasets, and predictive modeling to accelerate breakthroughs in the lab. Learn how Luma is powering innovation. dotmatics.com/blog/ai-enable…

One of the biggest hurdles researchers are still facing is moving data across the their research workflow. Dotmatics Luma + OMIQ integration streamlines your workflow, automates dataflows, and accelerates analysis—so you can focus on discoveries. dotmatics.com/blog/end-to-en…

📺 In this recent ABC30 Fresno interview, our VP of Science & Technology, Philip Mounteney, shares how Dotmatics AI-powered solutions are accelerating research, reducing costs, and helping scientists get life-saving medicines to patients faster. abc30.com/post/how-ai-ca…

📣 Don't miss our upcoming webinar: Lab Instrument Harmonization with Luma Lab Connect, on April 24th, 2025. 🔗 Register now: dotmatics.zoom.us/webinar/regist…

🚀Exciting news: Dotmatics has signed an agreement to be acquired by Siemens. Together, we’ll connect scientific design, discovery & manufacturing — helping life sciences teams accelerate innovation and impact. dotmatics.com/news/dotmatics…